Literature DB >> 31701441

Diabetic Nephropathy: An Overview.

Manpreet K Sagoo1, Luigi Gnudi2.   

Abstract

Diabetic nephropathy (DN) is one of the most feared diabetic chronic microvascular complications and the major cause of end-stage renal disease (ESRD). The classical presentation of DN is characterized by hyperfiltration and albuminuria in the early phases which is then followed by a progressive renal function decline. The presentation of diabetic kidney disease (DKD) can vary especially in patients with T2DM where concomitant presence of other glomerular/tubular pathologies and severe peripheral vascular disease can become important confounders. All-cause mortality in individuals with DKD is approximately 30 times higher than that in diabetic patients without nephropathy and a great majority of patients with DKD will die from cardiovascular disease before they reach ESRD. The management of metabolic and hemodynamic perturbations for the prevention and for the delay of progression of DKD is very important. DKD is a global challenge and a significant social and economic burden; research should aim at developing new ideas to tackle this devastating condition.

Entities:  

Keywords:  Diabetes mellitus; Diabetic kidney disease; Epidemiology; Management; Pathogenesis

Mesh:

Year:  2020        PMID: 31701441     DOI: 10.1007/978-1-4939-9841-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  34 in total

1.  Alteration of gut microbial profile in patients with diabetic nephropathy.

Authors:  Xi Du; Jia Liu; Yu Xue; Xiangyun Kong; Chunxiao Lv; Ziqiang Li; Yuhong Huang; Baohe Wang
Journal:  Endocrine       Date:  2021-04-27       Impact factor: 3.633

2.  [Exploring the therapeutic mechanism of Longqi Fang for diabetic kidney disease based on network pharmacology and verification in rats].

Authors:  L Xing; W Xing; H Guo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-02-20

3.  The promising significance of liraglutide combined with dapagliflozin or empagliflozin in the prevention of early diabetic nephropathy.

Authors:  Qin Li; Xing Wang; Aili Guo; Wenxia Zheng; Jin Bi; Yan He; Qiong Luo
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

4.  Relationship of Soluble Klotho and Early Stage of Diabetic Nephropathy: A Systematic Review and Meta-Analysis.

Authors:  Caihong Xin; Xin Sun; Zheng Li; Tianshu Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-27       Impact factor: 6.055

5.  Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy.

Authors:  Xueling Liao; Yanan Xiao; Ulf Elbelt; Karsten H Weylandt; Kanghui Li; Jie Deng; Ning Zeng; Chao Xue
Journal:  Biomed Res Int       Date:  2022-05-25       Impact factor: 3.246

6.  Impact of lifestyle education for type 2 diabetes mellitus: Protocol for a randomized controlled trial.

Authors:  Jingjing Zhu; Min Chen; Yuzi Pang; Shumin Li
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

7.  Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Authors:  Tatsuo Yanagawa; Keiko Koyano; Koichiro Azuma
Journal:  Diabetol Int       Date:  2021-01-02

Review 8.  The Role of Inflammation in Diabetic Retinopathy.

Authors:  John V Forrester; Lucia Kuffova; Mirela Delibegovic
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

Review 9.  The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.

Authors:  Kamila Puchałowicz; Monika Ewa Rać
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

10.  Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.

Authors:  Yan Li; Lei Wang; Bojun Xu; Liangbin Zhao; Li Li; Keyang Xu; Anqi Tang; Shasha Zhou; Lu Song; Xiao Zhang; Huakui Zhan
Journal:  J Diabetes Res       Date:  2021-02-05       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.